AUPH·05156V102·US·equity·Healthcare - Biotechnology-Activist
AUPH (AURINIA PHARMACEUTICALS INC) is held by 139 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($116.3M), TWO SIGMA INVESTMENTS, LP ($50.8M), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ($48.7M). Net institutional sentiment: Mixed.
See how AUPH's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer